Does Rallies show 13F holders for ECG?

Yes. Rallies tracks hedge fund and 13F ownership data for ECG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ECG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ECG. It does not provide personalized investment advice.

ECG (Everus Construction Group, Inc.) Stock Analysis - Hedge Fund Holdings

Everus Construction Group, Inc. (ECG) is a publicly traded Industrials sector company. As of May 21, 2026, ECG trades at $148.75 with a market cap of $7.58B and a P/E ratio of 37.36. ECG moved +1.64% today. Year to date, ECG is +62.23%; over the trailing twelve months it is +152.20%. Its 52-week range spans $31.38 to $171.58. Analyst consensus is buy with an average price target of $159.14. Rallies surfaces ECG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ECG stock?

Hedge funds tracked by Rallies that own ECG include Corvex Management, 1060 Capital, Pinebridge Investments, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Everus Construction Group, Inc..

ECG Key Metrics

Key financial metrics for ECG
Metric	Value
Price	$148.75
Market Cap	$7.58B
P/E Ratio	37.36
EPS	$3.95
Dividend Yield	0.00%
52-Week High	$171.58
52-Week Low	$31.38
Volume	0
Avg Volume	0
Revenue (TTM)	$3.75B
Net Income	$201.77M
Gross Margin	12.12%

Top Hedge Funds Holding ECG

Corvex Management holds 322.71K shares of ECG, changed +0.00% as of Dec 31, 2024.
1060 Capital holds 90.00K shares of ECG, changed +0.00% as of Dec 31, 2024.
Pinebridge Investments holds 25.73K shares of ECG, changed +0.00% as of Dec 31, 2024.
Bridgewater Associates holds 8.03K shares of ECG, changed +0.00% as of Dec 31, 2025.
Mangrove Partners holds 2.14K shares of ECG, changed +0.00% as of Mar 31, 2026.

Latest ECG News

Everus (ECG) rises after record Q1 results and higher 2026 guidance — May 6, 2026
Everus Construction Group jumps 4% as market positions ahead of Q1 earnings — May 5, 2026
Everus Construction Group jumps ahead of May 5 Q1 earnings amid fresh analyst bullishness — May 4, 2026
Everus Construction jumps as Vanguard discloses 5.24% stake in new 13G filing — Apr 30, 2026
ECG slips as Everus’ $158M SE&M acquisition refocuses investors on 2026 outlook — Apr 28, 2026

Recent ECG Insider Trades

Hernandez Helena Mercedes bought 250 (~$23.05K) on Dec 8, 2025.
Marcy Maximillian J bought 1.30K (~$50.69K) on Feb 25, 2025.
Ryan Edward A bought 1.40K (~$53.23K) on Feb 25, 2025.

ECG Analyst Consensus

7 analysts cover ECG: 0 strong buy, 3 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $159.14.

Common questions about ECG

Who owns ECG stock?: Hedge funds tracked by Rallies that own ECG include Corvex Management, 1060 Capital, Pinebridge Investments, Bridgewater Associates, and Mangrove Partners. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Everus Construction Group, Inc..
Does Rallies show 13F holders for ECG?: Yes. Rallies tracks hedge fund and 13F ownership data for ECG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ECG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ECG. It does not provide personalized investment advice.